NRAS
NRAS (NRAS proto-oncogene, GTPase, also known as N-ras) is a membrane-associated small GTPase of the Ras family. It acts as a signal transducer in the Ras-MAPK pathway, regulating cell proliferation and survival. Browse Assay Genie's current range of NRAS research reagents below, or read on for the biology behind the target.
NRAS is a signal transducer in the Ras-MAPK signalling pathway, which regulates cell proliferation and survival. Like other Ras proteins, it binds GDP and GTP and possesses intrinsic GTPase activity. The protein is activated by a guanine nucleotide-exchange factor and inactivated by a GTPase-activating protein, so it works as a molecular switch between its GTP-bound and GDP-bound states.
The NRAS gene encodes a membrane protein that belongs to the small GTPase superfamily, Ras family, and sits in the HGNC RAS type GTPase family. NRAS shuttles between the Golgi apparatus and the plasma membrane, and this trafficking is regulated by palmitoylation and depalmitoylation through the ZDHHC9-GOLGA7 complex. UniProt records its location as the cell membrane and the Golgi apparatus membrane. The NRAS protein is also recognised by LZTR1, which mediates its ubiquitination by a BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase complex.
The gene was first described as an N-ras oncogene, and earlier names include neuroblastoma RAS viral (v-ras) oncogene homolog. Mutations in the NRAS gene have been associated with somatic rectal cancer, follicular thyroid cancer, autoimmune lymphoproliferative syndrome, Noonan syndrome and juvenile myelomonocytic leukaemia. Mouse and rat both carry an orthologous Nras gene.
NRAS transduces signals through the Ras-MAPK pathway that regulate cell proliferation and survival, making it a central node for studying growth control.
Mutations in the NRAS oncogene are associated with somatic rectal cancer, follicular thyroid cancer and juvenile myelomonocytic leukaemia.
NRAS variants are linked to Noonan syndrome and autoimmune lymphoproliferative syndrome, supporting research into RASopathies and immune regulation.
NRAS shuttles between the Golgi and plasma membrane under palmitoylation control by ZDHHC9-GOLGA7, and is targeted for ubiquitination via LZTR1.
NRAS is a small GTPase that acts as a signal transducer in the Ras-MAPK pathway, regulating cell proliferation and survival. It binds GDP and GTP, has intrinsic GTPase activity, is activated by a guanine nucleotide-exchange factor and is inactivated by a GTPase-activating protein.
The HGNC name is NRAS proto-oncogene, GTPase, and the UniProt protein name is GTPase NRas. The alias is N-ras. Earlier names were neuroblastoma RAS viral (v-ras) oncogene homolog and neuroblastoma RAS viral oncogene homolog, reflecting its identification as an oncogene.
Mutations in the NRAS gene have been associated with somatic rectal cancer, follicular thyroid cancer, autoimmune lymphoproliferative syndrome, Noonan syndrome and juvenile myelomonocytic leukaemia. Mouse and rat have an orthologous Nras gene; check the datasheet of any product for its validated reactivity.
Other Ras-family GTPases, regulators of Ras localisation and turnover, and Ras-MAPK pathway components.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P01111; product specifications from Assay Genie datasheets.